Skip to content

Effectiveness of sternocleidomastoid muscle flap in preventing of pharyngocutaneous fistula after total laryngectomy: An Open-label Clinical Trial.

Effectiveness of sternocleidomastoid muscle flap in preventing of pharyngocutaneous fistula after total laryngectomy: An Open-label Clinical Trial.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230916001
Enrollment
16
Registered
2023-09-16
Start date
2021-06-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sternocleidomastoid muscle flap in preventing of pharyngocutaneous fistula after total laryngectomy Total laryngectomy pharyngocutaneous fistula sternocleidomastoid muscle flap

Interventions

The surgical technique (SCM flap) involved the following steps: 1. The distal attachment of the sternal head was cut in full thickness. 2. The flap was dissected superiorly until the middle of the
sternocleidomastoid muscle flap ,Control group

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. patients who underwent total laryngectomy 2. aged up to 60 years 3. not received preoperative radiotherapy

Exclusion criteria

Exclusion criteria: Patients were required to have a preoperative hemoglobin level of 12.5 gm/dL or higher, and those with early-stage laryngeal cancer.

Design outcomes

Primary

MeasureTime frame
pharyngocutaneous fistula 2 weeks or more Barium swallowing

Secondary

MeasureTime frame
Hospital stay From the day of admission to the day of discharge(mean days) Number of days from admission to discharge,Pain score Post-operative day 1 Visual Analog Scale (VAS),Blood loss During surgery Surgical suction containers to determine volume of blood loss(mL),Cost At the point of discharge Total hospitalization costs, including surgical procedures, laboratory tests, X-ray imaging, medications, and other associated expenses, as detailed in the final billing statement.

Countries

Thailand

Contacts

Public ContactNarut Wongsakorn

Sawanpracharak Hospital

narutwongsakorn@gmail.com056219899

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026